First Light Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.9M | Sell |
|
|||||
|
2025
Q1 | $22.9M | Sell |
|
|||||
|
2024
Q4 | $32.1M | Buy |
|
|||||
|
2024
Q3 | $41.9M | Sell |
|
|||||
|
2024
Q2 | $39.6M | Buy |
|
|||||
|
2024
Q1 | $36.9M | Buy |
|
|||||
|
2023
Q4 | $35.6M | Sell |
|
|||||
|
2023
Q3 | $40.1M | Buy |
|
|||||
|
2023
Q2 | $27.2M | Buy |
|
|||||
|
2023
Q1 | $9.45M | Buy |
|
|||||
|
2022
Q4 | $10.9M | Sell |
|
|||||
|
2022
Q3 | $18.8M | Buy |
|
|||||
|
2022
Q2 | $27M | Buy |
|
|||||
|
2022
Q1 | $31.8M | Buy |
|
|||||
|
2021
Q4 | $34.6M | Sell |
|
|||||
|
2021
Q3 | $39.8M | Buy |
|
|||||
|
2021
Q2 | $21.9M | Buy |
|
|||||
|
2021
Q1 | $24.8M | Buy |
|
|||||
|
2020
Q4 | $29.6M | Buy |
|
|||||
|
2020
Q3 | $15.2M | Sell |
|
|||||
|
2020
Q2 | $18.5M | Sell |
|
|||||
|
2020
Q1 | $15.2M | Buy |
|
|||||
|
2019
Q4 | $7.45M | Sell |
|
|||||
|
2019
Q3 | $7.69M | Sell |
|
|||||
|
2019
Q2 | $11.4M | Buy |
|